There are many optically active organic compounds of biological and medicinal significance. For example, statine analogs, antibiotics, anesthetics, ACE inhibitors, macrolides, heterocyclic compounds, unusual amino acids, and insect pheromones all contain stereogenic centers. There is, therefore, a continuous need for new asymmetric methodology. A major objective of Bakthan Singaram's research program is the development of asymmetric and/or enantioselective methods.
Within this context, an important aspect of his study is to develop novel and efficient chiral auxiliaries and catalysts derived from terpenes, organic acids, and other naturally occurring organic compounds. These compounds are tested for their efficiency in asymmetric reduction and asymmetric allylmetallation reactions. Current emphasis is centered in the areas of organometallics, heteroatom stabilized carbanions, and imine intermediates.
